P675: IMATINIB THERAPY IN PREVIOUSLY UNTREATED CHRONIC MYELOID LEUKAEMIA PATIENTS WHO ACHIEVE MMR AFTER 12 MONTHS THERAPY WITH DASATINIB: A STRATEGY TO AVOID LONG TERM OFF TARGET TOXICITY
Lucy Pemberton,
Katrina Sharples,
Yujin Kim,
Emma-Jane Mcdonald,
Humphrey Pullon,
Bart Baker,
Merit Hanna,
Gordon Royle,
Shahidul Islam,
Victoria Campion,
Michael Findlay,
Peter Browett
Affiliations
Lucy Pemberton
1 Te Whatu Ora Southern, Dunedin, New Zealand
Katrina Sharples
2 University of Otago, Dunedin, New Zealand
Yujin Kim
3 Cancer Trials New Zealand, Auckland, New Zealand
Emma-Jane Mcdonald
5 Te Whatu Ora, Christchurch, New Zealand
Humphrey Pullon
6 Pathlab Tristram St, Hamilton, New Zealand
Bart Baker
7 Te Whatu Ora, Palmerston North, New Zealand
Merit Hanna
8 Te Whatu Ora, Auckland
Gordon Royle
8 Te Whatu Ora, Auckland
Shahidul Islam
9 Te Whatu Ora, Hamilton, New Zealand
Victoria Campion
10 Te Whatu Ora, Wellington, New Zealand
Michael Findlay
3 Cancer Trials New Zealand, Auckland, New Zealand
Peter Browett
4 University of Auckland, Grafton Campus, Auckland, New Zealand